Published in Br Med J (Clin Res Ed) on January 05, 1985
MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party. Br Med J (Clin Res Ed) (1985) 4.98
Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer. Br J Cancer (2006) 1.99
Using N-of-1 trials to improve patient management and save costs. J Gen Intern Med (2010) 1.80
Just-in-time information improved decision-making in primary care: a randomized controlled trial. PLoS One (2008) 1.32
The Pediatric Obsessive-Compulsive Disorder Treatment Study II: rationale, design and methods. Child Adolesc Psychiatry Ment Health (2009) 1.10
Cognitive-behavioral therapy for binge eating disorder in adolescents: study protocol for a randomized controlled trial. Trials (2013) 0.80
Effects of acebutolol on the serum lipid profile. Drugs (1988) 0.78
Clinical trials, statistics, and dilemmas. Arch Dis Child (1988) 0.75
Social facilitation maintenance treatment for adults with obesity: study protocol for a randomised-controlled feasibility study (SFM study). BMJ Open (2016) 0.75
Development of new drugs in man: a review. J R Soc Med (1986) 0.75
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55
Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet (1980) 10.23
Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet (1981) 7.05
Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25
D-penicillamine treatment improves survival in primary biliary cirrhosis. Lancet (1981) 1.45
Restricted randomization designs in clinical trials. Biometrics (1979) 1.38
Guidelines for publishing papers on cancer clinical trials: responsibilities of editors and authors. J Clin Oncol (1983) 1.07
Practical experience of randomization in cancer trials: an international survey. Br J Cancer (1982) 0.99
Medical Research Council Vitamin Study. Lancet (1984) 0.88
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics (1975) 18.25
British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J (Clin Res Ed) (1981) 14.25
Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) (1983) 10.90
Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet (2000) 9.80
Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med (1987) 8.64
Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med (1992) 7.33
British Regional Heart Study: geographic variations in cardiovascular mortality, and the role of water quality. Br Med J (1980) 5.56
Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health (1985) 5.53
Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants. Br Med J (1980) 4.97
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med (1998) 4.68
Randomized trials or observational tribulations? N Engl J Med (2000) 4.49
Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09
Identifying men at high risk of heart attacks: strategy for use in general practice. Br Med J (Clin Res Ed) (1986) 3.76
Can meta-analyses be trusted? Lancet (1991) 3.43
Long-term survival of patients with breast cancer: a study of the curability of the disease. Br Med J (1979) 3.29
An epidemiological study of workers producing enzyme washing powders. Lancet (1970) 2.98
A scoring system to identify men at high risk of a heart attack. Health Trends (1987) 2.58
Risk factors for stroke in middle aged British men. BMJ (1991) 2.44
Lead exposure and children's intellectual performance. Int J Epidemiol (1987) 2.30
Regression of area mortality rates on explanatory variables: what weighting is appropriate? J R Stat Soc Ser C Appl Stat (1981) 2.26
Giving up smoking and the risk of heart attacks. A report from The British Regional Heart Study. Lancet (1986) 2.19
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial. Lancet (2005) 2.15
Allocation of patients to treatment in clinical trials. Biometrics (1979) 2.13
On the design and analysis of randomized clinical trials with multiple endpoints. Biometrics (1993) 2.13
Short-term effects of air pollution on daily mortality in Athens: a time-series analysis. Int J Epidemiol (1994) 2.03
Effects of alcohol and smoking on blood lead in middle-aged British men. Br Med J (Clin Res Ed) (1982) 2.03
The combination of randomized and historical controls in clinical trials. J Chronic Dis (1976) 2.00
Issues in data monitoring and interim analysis of trials. Health Technol Assess (2005) 1.96
Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet (1998) 1.94
Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group. Am Rev Respir Dis (1992) 1.89
Biochemical and haematological response to alcohol intake. Ann Clin Biochem (1985) 1.84
British blood cholesterol values and the American consensus. Br Med J (Clin Res Ed) (1985) 1.80
Blood pressure and hypertension in middle-aged British men. J Hypertens (1988) 1.80
Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall study. BMJ (1991) 1.79
Health service costs of coronary angioplasty and coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet (1994) 1.78
Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial. Eur Heart J (2004) 1.74
High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men. Br Med J (Clin Res Ed) (1986) 1.73
Commuter travel and sickness absence of London office workers. Br J Prev Soc Med (1972) 1.72
Blood lead concentration, blood pressure, and renal function. Br Med J (Clin Res Ed) (1984) 1.60
Stopping rules and estimation problems in clinical trials. Stat Med (1988) 1.58
Ethnic differences in certified sickness absence. Br J Ind Med (1982) 1.57
Interim analyses for randomized clinical trials: the group sequential approach. Biometrics (1982) 1.57
Differences in physical characteristics, perinatal histories, and social backgrounds between children with growth hormone deficiency and constitutional short stature. Arch Dis Child (1981) 1.56
Alcohol and ischaemic heart disease in middle aged British men. Br Med J (Clin Res Ed) (1987) 1.51
[The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies]. Internist (Berl) (2008) 1.47
Long term survival analysis: the curability of breast cancer. Stat Med (1983) 1.44
Effects of tap water lead, water hardness, alcohol, and cigarettes on blood lead concentrations. J Epidemiol Community Health (1983) 1.43
Mortality of shift and day workers 1956-68. Br J Ind Med (1972) 1.38
Absenteeism of shift and day workers. A study of six types of shift system in 29 organizations. Br J Ind Med (1972) 1.34
Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. Biometrics (1987) 1.30
Impact of missing data due to drop-outs on estimators for rates of change in longitudinal studies: a simulation study. Stat Med (2001) 1.28
Headaches and migraine in colour retouchers. Br J Ind Med (1970) 1.28
The variability of serum cholesterol measurements: implications for screening and monitoring. J Clin Epidemiol (1990) 1.26
The agonising negative trend in monitoring of clinical trials. Lancet (1999) 1.25
Post-war trends in sickness absence and unemployment in Great Britain. Lancet (1969) 1.22
Time trends in serum cholesterol before cancer death. Epidemiology (1997) 1.15
Multiple regression in geographical mortality studies, with allowance for spatially correlated errors. Biometrics (1983) 1.15
[Contribution of lead in drinking water to blood-lead]. Lancet (1977) 1.15
Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard. Cancer (1976) 1.14
Size of cancer clinical trials and stopping rules. Br J Cancer (1978) 1.13
Factors influencing household water lead: a British national survey. Arch Environ Health (1980) 1.13
Domiciliary thrombolysis by general practitioners. BMJ (1992) 1.11
Assessing treatment-time interaction in clinical trials with time to event data: a meta-analysis of hypertension trials. Stat Med (1998) 1.10
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol. Diabetologia (2005) 1.09
Linearly divergent treatment effects in clinical trials with repeated measures: efficient analysis using summary statistics. Stat Med (1997) 1.09
Rosiglitazone RECORD study: glucose control outcomes at 18 months. Diabet Med (2007) 1.08
Wheeze associated with prenatal tobacco smoke exposure: a prospective, longitudinal study. ALSPAC Study Team. Arch Dis Child (2000) 1.07
Parental death from heart disease and the risk of heart attack. Eur Heart J (1988) 1.06
Factorial trials in cardiology: pros and cons. Eur Heart J (1994) 1.03
Neonatal head circumference, neonatal weight, and risk of hayfever, asthma and eczema in a large cohort of adolescents from Sheffield, England. Clin Exp Allergy (2003) 1.02
Risk factors for ischaemic heart disease in British men. Br Heart J (1987) 1.01
The role of risk factors in heart attacks occurring in men with pre-existing ischaemic heart disease. Br Heart J (1988) 1.01
Variation in the incidence of diverticular disease within the city of Edinburgh. Gut (1977) 1.00
Practical experience of randomization in cancer trials: an international survey. Br J Cancer (1982) 0.99
Estimation and comparison of rates of change in longitudinal studies with informative drop-outs. Stat Med (1999) 0.99
Sample size requirements for prospective studies, with examples for coronary heart disease. J Clin Epidemiol (1989) 0.99
Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic System. Eur Heart J (1998) 0.98
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. Heart (2006) 0.94
The contribution of drinking water lead to maternal blood lead concentrations. Clin Chim Acta (1979) 0.94
Prognosis of patients with acute myocardial infarction admitted to a coronary care unit. II. Survival after hospital discharge. Br Heart J (1977) 0.93
Relationship between sickness absence and meteorological factors. Br J Prev Soc Med (1972) 0.91
Some studies of maternal and infant lead exposure in Glasgow. Scott Med J (1982) 0.91
The impact of stopping rules on heterogeneity of results in overviews of clinical trials. Biometrics (1992) 0.89
Predictive value of repeated measurements of CD4 lymphocyte counts on progression to AIDS. AIDS (1994) 0.88
Prediction of short-term survival with an application in primary biliary cirrhosis. Stat Med (1992) 0.88
Long-term survival in patients with advanced immunodeficiency. AIDS (1997) 0.87
Randomised clinical trials. Br Med J (1977) 0.87
Reduction in exposure to lead from drinking water and its effect on blood lead concentrations. Hum Toxicol (1984) 0.86
The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial. Heart (2007) 0.86
Prognosis of patients with acute myocardial infarction admitted to a coronary care unit. I: Survival in hospital. Br Heart J (1977) 0.86
Prognostic scores for detecting a high risk group: estimating the sensitivity when applied to new data. Stat Med (1990) 0.83
Evidence for temporary slowing of mucociliary clearance in the lung caused by tobacco smoking. Nature (1971) 0.83
A comparison of two methods for the estimation of precision with incomplete longitudinal data, jointly modelled with a time-to-event outcome. Stat Med (2003) 0.82
Lead and children's IQ. Lancet (1987) 0.82
The British Regional Heart Study: cardiovascular mortality and water quality. J Environ Pathol Toxicol (1980) 0.81
Cholesterol in elderly women. Lancet (1992) 0.80
State of the art in comparative cancer clinical trials. Cancer (1987) 0.80
Catch-up growth in cortisone-treated rats: effects of calcium and vitamin D. Pediatr Res (1978) 0.80
Blood lead and blood pressure. Br Med J (Clin Res Ed) (1985) 0.79